12 Cases of CVST Reported for Ad26.COV2.S Vaccine in the U.S.
TUESDAY, May 4, 2021 (HealthDay News) — Twelve cases of cerebral venous sinus thrombosis...
Read More
Hematology/Oncology
USPSTF: Evidence Lacking for Use of Vitamins for CVD, Cancer Prevention
TUESDAY, May 4, 2021 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF)...
Read More
Many Americans Wrong About Sun’s Skin Cancer Dangers: Poll
TUESDAY, May 4, 2021 (HealthDay News) — A new survey reveals that one-third of Americans...
Read More
SLNB, RT Not Tied to Better Outcomes in Older Women With Breast Cancer
WEDNESDAY, May 5, 2021 (HealthDay News) — For older patients with estrogen receptor...
Read More
Universal Multigene Panel Test in CRC IDs Heritable Mutations
WEDNESDAY, May 5, 2021 (HealthDay News) — One in six patients with colorectal cancer (CRC)...
Read More
COVID-19-Associated Cancer Screening Deficit Quantified in U.S.
WEDNESDAY, May 5, 2021 (HealthDay News) — The absolute deficit in screening associated with...
Read More
Dihydroartemisinin regulates apoptosis, migration, and invasion of ovarian cancer cells via mediating RECK.
Dihydroartemisinin (DHA) possesses an inhibitory effect on ovarian cancer and promotes...
Read More
Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53.
Ovarian cancer (OvCA) remains one of the most devastating malignancies, but treatment options are...
Read More
Cisatracurium inhibits the growth and induces apoptosis of ovarian cancer cells by promoting lincRNA-p21.
As a common muscle relaxant, cisatracurium has shown good antitumor effect on some tumors. Recent...
Read More
Effect of COVID-19 on Breast Cancer Treatment Examined
MONDAY, May 3, 2021 (HealthDay News) — More patients with estrogen receptor (ER)-positive,...
Read More
Cryoablation Promising for Early Breast Cancer
MONDAY, May 3, 2021 (HealthDay News) — Cryoablation seems promising for early breast cancer...
Read More
Fertility Concerns Impact Treatment Decisions in Breast Cancer
FRIDAY, April 30, 2021 (HealthDay News) — Fertility concerns impact decision-making about...
Read More
Occult Brain Mets Detected in Patients With Advanced Renal Cancer
MONDAY, May 3, 2021 (HealthDay News) — Occult brain metastasis is identified in about 4...
Read More
Mortality Risk Up for Fragmented Care After Complex Cancer Surgery
MONDAY, May 3, 2021 (HealthDay News) — Travel distance and timing contribute to care...
Read More
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study.
To explore the clinical and biological prognostic factors for advanced ovarian cancer patients...
Read More
ONC201 induces the unfolded protein response (UPR) in high- and low-grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity.
Treatment of both platinum resistant high grade (HG) and low-grade (LG) ovarian cancer (OVCA)...
Read More
Platinum-based Chemotherapy and Bevacizumab Instigate the Destruction of Human Ovarian Cancers via Different Signaling Pathways.
The standard chemotherapy regimens of ovarian cancer are platinum-based chemotherapy (carboplatin...
Read More
Urinary Incontinence Surgery in Women Not Tied to Pelvic Cancer
THURSDAY, April 29, 2021 (HealthDay News) — Stress urinary incontinence surgery, with or...
Read More
Safety, Efficacy of Vadadustat Explored for CKD
THURSDAY, April 29, 2021 (HealthDay News) — Vadadustat met the noninferiority criteria for...
Read More
Safety, Efficacy of Vadadustat Explored for CKD
THURSDAY, April 29, 2021 (HealthDay News) — Vadadustat met the noninferiority criteria for...
Read More